Literature DB >> 22820275

Atomoxetine modulates spontaneous and sensory-evoked discharge of locus coeruleus noradrenergic neurons.

A Bari1, G Aston-Jones.   

Abstract

Atomoxetine (ATM) is a potent norepinephrine (NE) uptake inhibitor and increases both NE and dopamine synaptic levels in prefrontal cortex, where it is thought to exert its beneficial effects on attention and impulsivity. At the behavioral level, ATM has been shown to cause improvements on the measures of executive functions, such as response inhibition, working memory and attentional set shifting across different species. However, the exact mechanism of action for ATM's effects on cognition is still not clear. One possible target for the cognitive enhancing effects of ATM is the noradrenergic locus coeruleus (LC), the only source of NE to key forebrain areas such as cerebral cortex and hippocampus. Although it is known that ATM increases NE availability overall by blocking reuptake of NE, the effects of this agent on impulse activity of LC neurons have not been reported. Here, the effect of ATM (0.1-1 mg/kg, ip) on NE-LC neurons was investigated by recording extracellular activity of LC neurons in isoflurane-anesthetized rats. ATM caused a significant decrease of the tonic activity of LC single-units, although leaving intact the sensory-evoked excitatory component of LC phasic response. Moreover, the magnitude of the inhibitory component of LC response to paw stimulation was increased after 1 mg/kg of ATM and its duration was prolonged at 0.3 mg/kg. Together, these effects of ATM produced an increase in the phasic-to-tonic ratio of LC phasic response to sensory stimulation. ATM also modulated the average sensory-evoked local field potential (LFP) and spike-field coherence in LC depending on the dose tested. The lower dose (0.1 mg/kg) significantly decreased early positive and negative components of the sensory-evoked LFP response. Higher doses (0.3-1 mg/kg) initially increased and then decreased the amplitude of components of the evoked fields, whereas the spike-field coherence was enhanced by 1 mg/kg ATM across frequency bands. Finally, coherence between LC fields and EEG signals was generally increased by 1 mg/kg ATM, whereas 0.1 and 0.3 mg/kg respectively decreased and increased coherence values in specific frequency bands. Taken together these results suggest that ATM effects on LC neuronal activity are dose-dependent, with different doses affecting different aspects of LC firing. This modulation of activity of LC-NE neurons may play a role in the cognitive effects of ATM. This article is part of a Special Issue entitled 'Cognitive Enhancers'.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22820275      PMCID: PMC3445720          DOI: 10.1016/j.neuropharm.2012.07.020

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  158 in total

1.  Attenuation of emotional and nonemotional memories after their reactivation: role of beta adrenergic receptors.

Authors:  J Przybyslawski; P Roullet; S J Sara
Journal:  J Neurosci       Date:  1999-08-01       Impact factor: 6.167

Review 2.  Memory--a century of consolidation.

Authors:  J L McGaugh
Journal:  Science       Date:  2000-01-14       Impact factor: 47.728

3.  Characterization of noradrenaline release in the locus coeruleus of freely moving awake rats by in vivo microdialysis.

Authors:  Begoña Fernández-Pastor; Yolanda Mateo; Sonia Gómez-Urquijo; J Javier Meana
Journal:  Psychopharmacology (Berl)       Date:  2005-02-17       Impact factor: 4.530

4.  Alpha-receptor-mediated facilitation of somatosensory cortical neuronal responses to excitatory synaptic inputs and iontophoretically applied acetylcholine.

Authors:  B D Waterhouse; H C Moises; D J Woodward
Journal:  Neuropharmacology       Date:  1981-10       Impact factor: 5.250

5.  Mescaline and LSD facilitate the activation of locus coeruleus neurons by peripheral stimuli.

Authors:  G K Aghajanian
Journal:  Brain Res       Date:  1980-03-31       Impact factor: 3.252

6.  Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor.

Authors:  E H Wong; M S Sonders; S G Amara; P M Tinholt; M F Piercey; W P Hoffmann; D K Hyslop; S Franklin; R D Porsolt; A Bonsignori; N Carfagna; R A McArthur
Journal:  Biol Psychiatry       Date:  2000-05-01       Impact factor: 13.382

7.  Synchronous activity in locus coeruleus results from dendritic interactions in pericoerulear regions.

Authors:  M Ishimatsu; J T Williams
Journal:  J Neurosci       Date:  1996-08-15       Impact factor: 6.167

8.  Effect of various antidepressant drugs on the spontaneous firing rate of locus coeruleus and dorsal raphe neurons of the rat.

Authors:  J J Scuvée-Moreau; A E Dresse
Journal:  Eur J Pharmacol       Date:  1979-08-01       Impact factor: 4.432

9.  Broadband shifts in local field potential power spectra are correlated with single-neuron spiking in humans.

Authors:  Jeremy R Manning; Joshua Jacobs; Itzhak Fried; Michael J Kahana
Journal:  J Neurosci       Date:  2009-10-28       Impact factor: 6.167

10.  Caffeine effects on resting-state arousal in children.

Authors:  Robert J Barry; Adam R Clarke; Stuart J Johnstone; Christopher R Brown; Jason M Bruggemann; Irene van Rijbroek
Journal:  Int J Psychophysiol       Date:  2009-05-30       Impact factor: 2.997

View more
  28 in total

1.  Monoaminergic modulation of behavioural and electrophysiological indices of error processing.

Authors:  Jessica J M Barnes; Redmond G O'Connell; L Sanjay Nandam; Angela J Dean; Mark A Bellgrove
Journal:  Psychopharmacology (Berl)       Date:  2013-08-31       Impact factor: 4.530

2.  Interactions of nitric oxide with α2 -adrenoceptors within the locus coeruleus underlie the facilitation of inhibitory avoidance memory by agmatine.

Authors:  Gajanan P Shelkar; Sukanya G Gakare; Suwarna Chakraborty; Shashank M Dravid; Rajesh R Ugale
Journal:  Br J Pharmacol       Date:  2016-08-01       Impact factor: 8.739

3.  Differential attentional control mechanisms by two distinct noradrenergic coeruleo-frontal cortical pathways.

Authors:  Andrea Bari; Sangyu Xu; Michele Pignatelli; Daigo Takeuchi; Jiesi Feng; Yulong Li; Susumu Tonegawa
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-02       Impact factor: 11.205

4.  Non-motor predictors of freezing of gait in Parkinson's disease.

Authors:  Sarah J Banks; Ece Bayram; Guogen Shan; Denise R LaBelle; Brent Bluett
Journal:  Gait Posture       Date:  2018-12-06       Impact factor: 2.840

5.  Relationships between Pupil Diameter and Neuronal Activity in the Locus Coeruleus, Colliculi, and Cingulate Cortex.

Authors:  Siddhartha Joshi; Yin Li; Rishi M Kalwani; Joshua I Gold
Journal:  Neuron       Date:  2015-12-17       Impact factor: 17.173

6.  Atomoxetine accelerates attentional set shifting without affecting learning rate in the rat.

Authors:  Nelson K Totah; Nikos K Logothetis; Oxana Eschenko
Journal:  Psychopharmacology (Berl)       Date:  2015-07-24       Impact factor: 4.530

7.  The effect of single-dose methylphenidate on the rate of error-driven learning in healthy males: a randomized controlled trial.

Authors:  Jonathon R Howlett; He Huang; Cédric M Hysek; Martin P Paulus
Journal:  Psychopharmacology (Berl)       Date:  2017-09-01       Impact factor: 4.530

8.  Methylphenidate and atomoxetine enhance sensory-evoked neuronal activity in the visual thalamus of male rats.

Authors:  Rachel L Navarra; Brian D Clark; Gerard A Zitnik; Barry D Waterhouse
Journal:  Exp Clin Psychopharmacol       Date:  2013-10       Impact factor: 3.157

9.  Norepinephrine and impulsivity: effects of acute yohimbine.

Authors:  Alan C Swann; Marijn Lijffijt; Scott D Lane; Blake Cox; Joel L Steinberg; F Gerard Moeller
Journal:  Psychopharmacology (Berl)       Date:  2013-04-06       Impact factor: 4.530

10.  Mapping the effects of atomoxetine during response inhibition across cortical territories and the locus coeruleus.

Authors:  Rong Ye; Ndabezinhle Mazibuko; Jens Teichert; Ralf Regenthal; Angie A Kehagia; Mitul A Mehta
Journal:  Psychopharmacology (Berl)       Date:  2021-10-25       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.